Clinical trial
Pathophysiology Consequences of Obstructive Sleep Apnea in Biomarkers of Alzheimer's Disease. A Clinical Trial
NCT04905238 is registered in ClinicalTrials.gov with Alberto Alonso Fernandez as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pathophysiology Consequences of Obstructive Sleep Apnea in Biomarkers of Alzheimer's Disease. A Clinical Trial
- Lead sponsor
- Alberto Alonso Fernandez
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- July 31, 2020
- Completion date
- May 6, 2025
- Enrollment
- 130 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.